Even as the world fixates on hMPV, a genuine pandemic threat is emerging in the form of H5N1 bird flu. The virus has jumped ...

State and federal data show high levels of respiratory illnesses. Here's what to know about the illnesses circulating this ...

As of Dec. 28, Michigan’s flu shot uptake -- less than 2.5 million doses -- sat far below its goal of 4 million doses ...

Patients are piling up in Minnesota emergency rooms once again, but it’s not just from COVID-19. State health officials say ...

In China, reports of HMPV infections have indeed been rising in recent weeks in the more northerly regions. But so have ...

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...

Respiratory virus season is worsening. Nearly five years since the COVID-19 pandemic took hold, disease experts are urging ...

For immunocompromised individuals, antibody response to RSV vaccines is heterogeneous and about 40% do not seroconvert.

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, stomach flu and COVID-19.

A virus that's not well known to the public is spiking in China. CDC officials said HMPV is not a cause for concern here, nor is it a new virus.

Respiratory syncytial virus (RSV) was first identified as a cause of human infection more than six decades ago, after the virus was isolated from respiratory swabs from two children with outpatient ...

Texas Department of State Health Services data showed less than 50 HMPV-positive cases each week in December across the state ...